Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People who have been diagnosed with bladder cancer (either the type that has not grown into the muscle wall, or the type that has grown into the muscle wall but was treated without removing the bladder, or has not yet been treated), with the diagnosis made within the past 24 months through a camera examination of the bladder
- People who have received additional treatment placed directly into the bladder after their main treatment (this is allowed but not required)
- People who are willing and able to sign a written consent form agreeing to take part
- People who are willing to attend regular check-up appointments (every 3 months for 2 years for higher-risk cases, or every 6–12 months for 2 years for lower-risk cases)
Who may not be able to join:
- People who have had their entire bladder surgically removed
- People who have had another type of cancer (not counting bladder cancer, or certain common skin cancers) within the past 3 years
- People who currently have an active urinary tract infection or difficulty emptying their bladder
- People who have active kidney stones or bladder stones, or whose kidneys are not working well enough (based on a blood test result; the blood test must be from within the past 60 days, otherwise a repeat test will be needed)
- People who have tubes or stents placed in their urinary system or bowel connections to the urinary tract (confirm with trial site)
- People who have had any procedure or instrument used in their urinary tract within 10 days before signing the consent form
- People who are unable or unwilling to attend the required follow-up appointments
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hideki Furuya, PhD, Cedars-Sinai Medical Center
Phone: 310-423-5609
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity and specificity of multiplex ELISA assay will be confirmed by cystoscopy.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.